Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of MRI, CT and PFTs for Early Detection of CLAD
NCT06406777Phase 2Recruiting
- Start
- Mar 2025
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 2, open-label trial (3 arms). Primary endpoint: Forced expiratory volume in 1 second Decline at 3 months. Started Mar 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06406777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06406777.